Hematology and Oncology
Home Hematology and Oncology
Breast Implants Slightly Increase Risk of Breast ALCL
Implants tied to increased risk of anaplastic large-cell lymphoma; overall risk still very small
Immune-Related Adverse Events Up With Checkpoint Inhibitors
Most patients with cancer, autoimmune disease have improvement in events without discontinuing therapy
Few Immuno-Oncology Agents Reach ASCO Efficacy Thresholds
Durable survival, response rates rarely recognized as significant by current oncology value frameworks
HSPC-Derived CAR T-Cells Capable of Lasting Engraftment
Chimeric antigen receptor T-cells persisted more than 2 years without measurable toxicity in primate model
December 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for December 2017. This roundup includes...
Same-Day, Low-Dose Bowel Prep Feasible for Colonoscopy
For inpatients at high risk of poor bowel prep, same-day 1-liter polyethylene glycol-based prep effective
Laser Improves QOL for Breast Telangiectasia Due to Radiation
Significant improvements seen in emotional and functional Skindex-16 HR-QOL domains, overall score
ACOG Advocates Cascade Testing for Hereditary Gene Mutations
Ob-gyns should identify eligible patients, offer testing, and assist in decreasing barriers to testing
Pharmaceutical Aids Not Found to Be Helpful for Smoking Cessation
No evidence that varenicline, bupropion, or nicotine replacement increase probability of abstinence
Variation Seen in Hospice Use for Malignant Glioma
Differences by race, sex, age, level of education, urban versus rural residence identified
